Tag: Health Financing
-
Amendment of the TRIPS Agreement
WTO members on 6 December 2005 approved changes to the WTO’s intellectual property (TRIPS) agreement in order to make permanent a decision on patents and public health originally adopted in 2003. This was formally built into the TRIPS Agreement after acceptance of the Protocol amending the TRIPS Agreement by two thirds of the WTO’s members.…
-
Middle East and North Africa Position Statement on HIV/AIDS to the High-Level Meeting on AIDS
Middle East and North Africa Position Statement on HIV/AIDS to the UN General Assembly Special Session High-Level Meeting on AIDS 6 – 8 June 2016 We, the undersigned communities of the MENA region; regional an d national networks and civil society organizations and representatives of key populations1, youth organizations, PLHIV organizations and groups convened on…
-
Launch of the MENA Regional Platform on Global Fund and Civil Society
The Global Fund in the MENA region The Global Fund against AIDS, Tuberculosis and Malaria (GFATM) is the largest financing institution that supports government and civil society in their response to HIV, TB and malaria in the Middle East and North Africa (MENA) region. As of 2015, the GFATM is funding programs in the following…
-
Building Capacity on Intellectual Property, Free Trade Agreement and Access to Medicines Workshop
ATL MST – ITPC MENA WORKSHOP TUNISIA 16, 17 & 18 NOVEMBER 2015 One of the most pressing issues in the 21st century is the lack of availability of essential medicines to poor patients in underdeveloped and developing countries. The problem is attributed to the existing Intellectual Property Rights (IPR) regimes, which were not aligned…
-
Treatment Advocates Denounce Gilead’s Embargo against Thousands of Tunisians Suffering from HCV Infection
The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the Hepatitis C Virus (HCV), sofosbuvir, available to Tunisian patients. “For months, thousands of patients have been desperately waiting for access to sofosbuvir.…
-
Pharma Refuses to Ensure Access to Lifesaving Hepatitis C Treatment at Global Meeting
Bangkok, Thailand, February 28, 2014 —Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus (HCV) from six multinational pharmaceutical companies. Yet AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Roche refused to provide a plan for…
-
HIV Activists from the MENA Region Call on Gulf States to Contribute to the 4th Replenishment of the Global Fund
November 30, 2013 – On the occasion of World AIDS Day 2013, HIV treatment activists from the MENA region called on wealthy Gulf States to join the Global Fund donor’s community sharing responsibility and engagement in a common mission to defeat AIDS, tuberculosis and malaria. Next week (December 2-3, 2013), world leaders and donors will…